Antimalarials multiple choice questions

Anti Malarial Questions

No Comments

Photo of author

By Dhruv Mangukia

Question 1:
A traveler is planning a 7-day trip to a region with chloroquine-resistant P. falciparum. They decide to use Atovaquone-Proguanil (Malarone) for chemoprophylaxis. How many days before travel should the traveler start taking the medication?

A) 1-2 days
B) 3-4 days
C) 1 week
D) 2 weeks
E) 3 weeks

Click here to see the answer

Correct Answer: A) 1-2 days
Explanation: Atovaquone-Proguanil should be started 1-2 days before travel to a malaria-endemic area.


Question 2:
If a traveler is using Doxycycline for malaria prophylaxis in a region with chloroquine-resistant P. falciparum, and plans to stay in the area for 14 days, how many tablets will they need in total?

A) 14 tablets
B) 28 tablets
C) 42 tablets
D) 44 tablets
E) 46 tablets

Click here to see the answer

Correct Answer: E) 46 tablets
Explanation: The traveler needs to start Doxycycline 1-2 days before travel, take one tablet daily during the 14 days of travel, and continue for 28 days after leaving the area. Total = 2 (before travel) + 14 (during travel) + 28 (after travel) = 44 tablets.


Question 3:
For how many days should Chloroquine be continued after leaving a malaria-endemic area?

A) 3 days
B) 7 days
C) 2 weeks
D) 3 weeks
E) 4 weeks

Click here to see the answer

Correct Answer: E) 4 weeks
Explanation: Chloroquine should be continued for 4 weeks after leaving a malaria-endemic area.


Question 4:
A traveler chooses Mefloquine for malaria prophylaxis and plans to stay in the area for 6 weeks. If the traveler starts Mefloquine 3 weeks before travel, how many tablets will they need in total?

A) 7 tablets
B) 9 tablets
C) 10 tablets
D) 11 tablets
E) 13 tablets

Click here to see the answer

Correct Answer: E) 13 tablets
Explanation: The traveler needs to start Mefloquine 2-3 weeks before travel, take one tablet weekly during the 6 weeks of travel, and continue for 4 weeks after leaving the area. Total = 3 (before travel) + 6 (during travel) + 4 (after travel) = 13 tablets.


Question 5:
Which of the following medications is NOT recommended for malaria prophylaxis in pregnant women?

A) Mefloquine
B) Doxycycline
C) Chloroquine
D) Atovaquone-Proguanil
E) Primaquine

Click here to see the answer

Correct Answer: B) Doxycycline
Explanation: Doxycycline is contraindicated in pregnant women due to the risk of fetal harm. Mefloquine is typically used in pregnancy if travel to a malaria-endemic area is unavoidable.


Question 6:
A traveler is prescribed Primaquine for primary prophylaxis against P. vivax and P. ovale. If the traveler plans to stay in the area for 10 days, how many days after leaving the area should they continue taking the medication?

A) 2 days
B) 5 days
C) 7 days
D) 10 days
E) 14 days

Click here to see the answer

Correct Answer: C) 7 days
Explanation: Primaquine should be continued for 7 days after leaving the area.


Question 7:
If a traveler takes Chloroquine for a 14-day stay in an area with chloroquine-sensitive P. falciparum, how many tablets should they take in total?

A) 3 tablets
B) 5 tablets
C) 6 tablets
D) 7 tablets
E) 8 tablets

Click here to see the answer

Correct Answer: C) 6 tablets
Explanation: The traveler needs to start Chloroquine 1-2 weeks before travel, take one tablet weekly during the 2 weeks of travel, and continue for 4 weeks after leaving the area. Total = 2 (before travel) + 2 (during travel) + 4 (after travel) = 8 tablets.


Question 8:
Which malaria prophylaxis medication requires starting 2-3 weeks before travel?

A) Doxycycline
B) Atovaquone-Proguanil
C) Primaquine
D) Chloroquine
E) Mefloquine

Click here to see the answer

Correct Answer: E) Mefloquine
Explanation: Mefloquine is typically started 2-3 weeks before travel to ensure adequate blood levels.


Question 9:
A traveler is using Atovaquone-Proguanil (Malarone) for a 7-day trip to a malaria-endemic area. How many days in total will the traveler need to take the medication?

A) 7 days
B) 10 days
C) 14 days
D) 16 days
E) 20 days

Click here to see the answer

Correct Answer: D) 16 days
Explanation: The traveler needs to take Atovaquone-Proguanil 1-2 days before travel, during the 7-day trip, and for 7 days after leaving the area. Total = 2 (before travel) + 7 (during travel) + 7 (after travel) = 16 days.


Question 10:
Which malaria prophylaxis drug is contraindicated in patients with G6PD deficiency due to the risk of hemolysis?

A) Atovaquone-Proguanil
B) Doxycycline
C) Mefloquine
D) Primaquine
E) Chloroquine

Click here to see the answer

Correct Answer: D) Primaquine
Explanation: Primaquine can cause hemolysis in patients with G6PD deficiency and is contraindicated in these patients.


Question 11
A 45-year-old woman with rheumatoid arthritis is prescribed hydroxychloroquine for its disease-modifying effects. She is also taking digoxin for heart failure. Which of the following interactions is most likely between hydroxychloroquine and digoxin?

A) Hydroxychloroquine decreases digoxin levels, leading to subtherapeutic effects
B) Hydroxychloroquine increases digoxin levels, raising the risk of digoxin toxicity
C) Hydroxychloroquine has no significant interaction with digoxin
D) Hydroxychloroquine enhances the efficacy of digoxin
E) Hydroxychloroquine and digoxin have an antagonistic interaction, reducing the effectiveness of both drugs

Click here to see the answer

Correct Answer: B) Hydroxychloroquine increases digoxin levels, raising the risk of digoxin toxicity
Explanation: Hydroxychloroquine can increase plasma levels of digoxin, which raises the risk of digoxin toxicity. Patients taking both medications should have their digoxin levels monitored closely, and dose adjustments may be necessary.


Question 12
A 30-year-old man traveling to a malaria-endemic area is prescribed chloroquine as prophylaxis. He is also taking amiodarone for a cardiac arrhythmia. What is the most significant risk associated with the concomitant use of chloroquine and amiodarone?

A) Increased risk of gastrointestinal bleeding
B) Potential for severe hypotension
C) Prolongation of the QT interval, leading to arrhythmias
D) Decreased efficacy of chloroquine
E) Increased risk of liver toxicity

Click here to see the answer

Correct Answer: C) Prolongation of the QT interval, leading to arrhythmias
Explanation: Both chloroquine and amiodarone have the potential to prolong the QT interval, increasing the risk of life-threatening arrhythmias, such as torsades de pointes. Caution should be exercised when using these drugs together, and ECG monitoring is recommended.


Question 13
A 50-year-old patient with a history of psoriasis is being considered for chloroquine therapy to treat malaria. What is the most appropriate course of action?

A) Start chloroquine therapy with close monitoring for skin reactions
B) Avoid chloroquine due to the risk of exacerbating psoriasis
C) Use a higher dose of chloroquine to counteract potential skin reactions
D) Administer chloroquine with corticosteroids to prevent psoriasis flares
E) Use an alternative antimalarial with no risk of affecting psoriasis

Click here to see the answer

Correct Answer: B) Avoid chloroquine due to the risk of exacerbating psoriasis
Explanation: Chloroquine can exacerbate psoriasis and is generally contraindicated in patients with a history of the condition. An alternative antimalarial that does not affect psoriasis should be used instead.


Question 14
A 35-year-old pregnant woman is diagnosed with malaria and is prescribed quinine. What is the most important consideration regarding the side effects of quinine in this patient?

A) Quinine may cause fetal hyperbilirubinemia
B) Quinine is associated with an increased risk of congenital malformations
C) Quinine can cause hypoglycemia, especially in pregnant women
D) Quinine increases the risk of thrombocytopenia in the fetus
E) Quinine can lead to excessive weight gain during pregnancy

Click here to see the answer

Correct Answer: C) Quinine can cause hypoglycemia, especially in pregnant women
Explanation: Quinine is known to cause hypoglycemia, which can be particularly severe in pregnant women. Blood glucose levels should be monitored closely, and appropriate measures should be taken to prevent hypoglycemia.


Question 15
A 28-year-old woman with systemic lupus erythematosus (SLE) has been prescribed hydroxychloroquine. She reports difficulty reading and blurred vision after several months of therapy. What is the most likely cause of her symptoms?

A) Retinal toxicity due to prolonged use of hydroxychloroquine
B) Increased intracranial pressure
C) Cataract formation from chronic use
D) Development of glaucoma
E) Allergic reaction to the medication

Click here to see the answer

Correct Answer: A) Retinal toxicity due to prolonged use of hydroxychloroquine
Explanation: Hydroxychloroquine can cause retinal toxicity, leading to blurred vision and difficulty reading. Long-term use increases the risk, and regular ophthalmologic monitoring is recommended to detect early signs of retinal damage.


Question 16
A 65-year-old man with chronic kidney disease (CKD) is prescribed mefloquine for malaria prophylaxis. Which of the following is the most important consideration in this patient?

A) Mefloquine should be avoided due to the risk of severe nephrotoxicity
B) The dose of mefloquine should be reduced due to decreased renal clearance
C) Mefloquine can cause QT prolongation, necessitating ECG monitoring
D) Mefloquine is safe to use in CKD with no dose adjustments
E) Mefloquine should be combined with another antimalarial for efficacy

Click here to see the answer

Correct Answer: C) Mefloquine can cause QT prolongation, necessitating ECG monitoring
Explanation: Mefloquine is associated with QT prolongation, which is particularly concerning in patients with CKD due to potential electrolyte imbalances. ECG monitoring is recommended in such patients to prevent arrhythmias.


Question 17
A 40-year-old man with no significant medical history is prescribed primaquine for the radical cure of Plasmodium vivax malaria. Which of the following should be assessed before initiating therapy?

A) Renal function
B) Liver function
C) Glucose-6-phosphate dehydrogenase (G6PD) deficiency
D) Electrocardiogram (ECG)
E) Complete blood count (CBC)

Click here to see the answer

Correct Answer: C) Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Explanation: Primaquine can cause hemolytic anemia in individuals with G6PD deficiency. It is crucial to test for G6PD deficiency before starting primaquine therapy to avoid this serious adverse effect.


Question 18
A 50-year-old woman is prescribed mefloquine for malaria prophylaxis before a trip to a malaria-endemic region. She has a history of anxiety and depression, which is currently well-controlled with sertraline. What is the most significant risk associated with the use of mefloquine in this patient?

A) Exacerbation of anxiety and depression
B) Increased risk of liver toxicity
C) Prolongation of the QT interval
D) Development of hypoglycemia
E) Interaction with sertraline leading to serotonin syndrome

Click here to see the answer

Correct Answer: A) Exacerbation of anxiety and depression
Explanation: Mefloquine is known to have CNS side effects, including the potential to exacerbate anxiety, depression, and cause neuropsychiatric symptoms such as vivid dreams, hallucinations, and even psychosis. It should be used with caution in patients with a history of psychiatric disorders.


Question 19
A 32-year-old woman with a history of epilepsy is prescribed chloroquine for the treatment of malaria. Which of the following is the most concerning potential side effect in this patient?

A) Hepatotoxicity
B) Hypoglycemia
C) Seizure exacerbation
D) Anemia
E) Stevens-Johnson syndrome

Click here to see the answer

Correct Answer: C) Seizure exacerbation
Explanation: Chloroquine has the potential to lower the seizure threshold, increasing the risk of seizures in patients with epilepsy. Close monitoring and potentially adjusting the anti-seizure medication may be necessary.


Question 20
A 60-year-old man is being treated with quinine for severe malaria. He has a history of tinnitus and reports that his symptoms have worsened since starting the medication. What is the most likely cause of his symptoms?

A) Quinine-induced ototoxicity
B) Quinidine-induced hepatotoxicity
C) Interaction with other antimalarial drugs
D) Central nervous system (CNS) toxicity
E) Peripheral neuropathy

Click here to see the answer

Correct Answer: A) Quinine-induced ototoxicity
Explanation: Quinine is associated with ototoxicity, which can manifest as tinnitus, hearing loss, and vertigo. These symptoms are often dose-dependent and reversible upon discontinuation of the drug.


Question 21
A 45-year-old patient is prescribed primaquine for the radical cure of Plasmodium vivax malaria. He is also taking metronidazole for a bacterial infection. What potential interaction should the healthcare provider monitor?

A) Increased risk of hemolysis
B) Prolongation of QT interval
C) CNS toxicity leading to seizures
D) Increased risk of metronidazole toxicity
E) Severe gastrointestinal symptoms

Click here to see the answer

Correct Answer: C) CNS toxicity leading to seizures
Explanation: Both primaquine and metronidazole have CNS effects, and their combination may increase the risk of CNS toxicity, potentially leading to seizures. Monitoring for neurological symptoms is essential in patients on this combination.


Question 22
A 35-year-old woman who is 20 weeks pregnant presents with malaria and is prescribed quinine. She complains of dizziness and confusion after starting the medication. What is the most likely explanation for these symptoms?

A) Quinine-induced hypoglycemia
B) CNS toxicity from quinine
C) Development of drug-induced psychosis
D) Quinine-related hepatotoxicity
E) Interaction with prenatal vitamins

Click here to see the answer

Correct Answer: B) CNS toxicity from quinine
Explanation: Quinine can cause CNS toxicity, particularly in higher doses, leading to symptoms such as dizziness, confusion, and even hallucinations. These effects are more common in patients who are sensitive to quinine.


Question 23
A 55-year-old patient with a history of chronic kidney disease is prescribed artesunate for severe malaria. Which of the following should be monitored most closely due to the patient’s condition?

A) Liver function tests
B) Retinal examination
C) Renal function and potential for nephrotoxicity
D) Blood glucose levels
E) CNS effects like dizziness and headache

Click here to see the answer

Correct Answer: C) Renal function and potential for nephrotoxicity
Explanation: Artesunate, particularly in patients with pre-existing kidney disease, requires close monitoring of renal function due to the risk of nephrotoxicity. Regular assessment of kidney function is essential during treatment.


Question 24
A 40-year-old man with no known medical history is prescribed doxycycline for malaria prophylaxis. He reports taking isotretinoin for acne. What is the primary concern with this drug combination?

A) Increased risk of hepatotoxicity
B) Enhanced photosensitivity reactions
C) Development of CNS symptoms like headaches and confusion
D) Decreased effectiveness of doxycycline
E) Increased gastrointestinal distress

Click here to see the answer

Correct Answer: B) Enhanced photosensitivity reactions
Explanation: Both doxycycline and isotretinoin can cause photosensitivity. When used together, the risk of severe sunburn and skin reactions is heightened. Patients should be advised to use sun protection and avoid excessive sun exposure.


Question 25
A 60-year-old man with a history of atrial fibrillation is prescribed quinidine for malaria treatment. He is also on warfarin for anticoagulation. What is the most important drug interaction to consider?

A) Increased risk of bleeding due to enhanced warfarin effect
B) Decreased effectiveness of quinidine due to warfarin
C) Risk of thromboembolism due to warfarin inactivation
D) Reduced anticoagulant effect of warfarin
E) Increased risk of CNS toxicity from quinidine

Click here to see the answer

Correct Answer: A) Increased risk of bleeding due to enhanced warfarin effect
Explanation: Quinidine can increase the effects of warfarin, leading to an increased risk of bleeding. Monitoring of INR levels and adjustment of the warfarin dose may be necessary.


Question 26
A 29-year-old woman is traveling to a malaria-endemic area and is prescribed doxycycline for prophylaxis. She also takes oral contraceptives. What is the primary concern with this combination?

A) Increased risk of thromboembolism
B) Decreased efficacy of oral contraceptives
C) Enhanced risk of liver toxicity
D) Severe gastrointestinal side effects
E) Increased photosensitivity

Click here to see the answer

Correct Answer: B) Decreased efficacy of oral contraceptives
Explanation: Doxycycline may reduce the effectiveness of oral contraceptives. It is advisable to use an additional method of contraception while taking doxycycline to prevent unintended pregnancy.


Question 27
A 32-year-old pregnant woman with a history of psychosis is planning to travel to a malaria-endemic region. She requires malaria prophylaxis but is concerned about the safety of her unborn child and the potential exacerbation of her psychiatric condition. Which of the following would be the most appropriate drug choice for malaria prophylaxis in this patient?

A) Mefloquine
B) Doxycycline
C) Chloroquine
D) Primaquine
E) Atovaquone-proguanil

Click here to see the answer

Correct Answer: C) Chloroquine
Explanation: Chloroquine is considered safe for use during pregnancy and does not have significant CNS side effects that could exacerbate psychosis. Mefloquine, although sometimes used in pregnancy, can exacerbate psychiatric conditions and is less preferred in patients with a history of psychosis. Doxycycline and primaquine are contraindicated in pregnancy, and atovaquone-proguanil is not the first choice during pregnancy due to limited safety data. Note that Hydroxychloroquine is the preferred drug in this case. But we don’t have that in option.


Question 28
What is the primary mechanism of action for Chloroquine in the treatment of malaria?
A) Inhibition of mitochondrial electron transport
B) Inhibition of dihydrofolate reductase
C) Inhibition of heme polymerase
D) Generation of reactive oxygen species
E) Interference with hemoglobin metabolism

Click here to see the answer

Correct Answer: C) Inhibition of heme polymerase
Explanation: Chloroquine inhibits heme polymerase, leading to the accumulation of toxic heme within the parasite, ultimately causing parasite death.


Question 29
Which antimalarial drug is known for its neuropsychiatric side effects, including vivid dreams, anxiety, and depression?
A) Chloroquine
B) Atovaquone-Proguanil
C) Mefloquine
D) Primaquine
E) Hydroxychloroquine

Click here to see the answer

Correct Answer: C) Mefloquine
Explanation: Mefloquine is associated with neuropsychiatric side effects, including vivid dreams, anxiety, depression, and, in severe cases, hallucinations and seizures.


Question 30
Which antimalarial drug is contraindicated in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of hemolytic anemia?
A) Chloroquine
B) Atovaquone-Proguanil
C) Mefloquine
D) Primaquine
E) Hydroxychloroquine

Click here to see the answer

Correct Answer: D) Primaquine
Explanation: Primaquine can cause hemolytic anemia in individuals with G6PD deficiency. Screening for G6PD deficiency is required before use.


Question 31
Which antimalarial combination is noted for its effectiveness in areas with multidrug-resistant malaria and has limited resistance observed?
A) Chloroquine
B) Atovaquone-Proguanil
C) Mefloquine
D) Primaquine
E) Hydroxychloroquine

Click here to see the answer

Correct Answer: B) Atovaquone-Proguanil
Explanation: Atovaquone-Proguanil (Malarone) is effective in treating and preventing chloroquine-resistant P. falciparum and has shown limited resistance, making it a preferred option in regions with multidrug-resistant malaria.


Question 32
What is a significant side effect associated with the long-term use of Hydroxychloroquine?
A) Nephrotoxicity
B) Neuropsychiatric effects
C) Retinopathy
D) Hemolytic anemia
E) Pancytopenia

Click here to see the answer

Correct Answer: C) Retinopathy
Explanation: Long-term use of Hydroxychloroquine can lead to retinopathy, a serious condition that can cause irreversible vision loss. Regular eye exams are recommended for patients on prolonged therapy.


Question 33
What concentration of DEET is recommended for children 8 years old to repel mosquitoes?
A) 5%
B) 10%
C) 15%
D) 20%
E) 30%

Click here to see the answer

Correct Answer: B) 10%
Explanation: For children around 8 years old, 10% DEET is recommended, which provides approximately 3 hours of mosquito repellent effect.


Question 34
Which of the following is true regarding the application of DEET in adults?
A) Use 5-10% DEET for up to 8 hours of protection
B) Apply DEET only once a day for prolonged protection
C) DEET should be applied to clothing only
D) Use 15-30% DEET, providing protection for up to 6 hours
E) DEET is not recommended for pregnant women

Click here to see the answer

Correct Answer: D) Use 15-30% DEET, providing protection for up to 6 hours
Explanation: Adults should use 15-30% DEET, which provides protection for up to 6 hours, and it can be applied a maximum of three times a day.


Question 35
Which of the following is a key guideline for applying DEET on the skin?
A) Apply to clothing only
B) Apply to exposed skin before outdoor activities
C) Apply directly to eyes and mucous membranes
D) Use DEET on infants under 6 months
E) Use DEET only during the winter season

Click here to see the answer

Correct Answer: B) Apply to exposed skin before outdoor activities
Explanation: DEET should be applied to exposed skin before outdoor activities, particularly during peak mosquito activity hours, while avoiding contact with eyes and mucous membranes.


Question 36
What is the primary use of permethrin in mosquito bite prevention?
A) To apply directly on the skin
B) To treat clothing and bed nets
C) To be used as an oral medication
D) To mix with DEET for enhanced protection
E) To apply on infants under 6 months old

Click here to see the answer

Correct Answer: B) To treat clothing and bed nets
Explanation: Permethrin is used to treat clothing and bed nets, providing additional protection by repelling and killing mosquitoes on contact.


Question 37
What is the recommended protective measure for young children in areas where malaria is prevalent?
A) Use of 30% DEET on their skin
B) Wearing dark-colored clothing
C) Applying permethrin directly to their skin
D) Using insecticide-treated bed nets
E) Taking vitamin supplements

Click here to see the answer

Correct Answer: D) Using insecticide-treated bed nets
Explanation: Insecticide-treated bed nets are recommended for young children, especially in areas where malaria is prevalent, as they offer effective protection during sleep.

Leave a Comment